A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"

NCT06165237 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric or Duodenal Ulcer

Interventions

DRUG: BR6001-1
DRUG: BR6001-2

Sponsor

Boryung Pharmaceutical Co., Ltd